Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 4,465-4,476 of 10,592
Drug study icon
CompletedNCT00759473

D-Cycloserine Facilitation of Cocaine - Cue Extinction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Mental healthDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Mental health
Drug study icon
CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
SuspendedNCT05046353

D-serine AudRem: R33 Phase

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Remote / online
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00826202

D-serine for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 13 Years to 35 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
TerminatedNCT01712646

Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 10 Years to 99 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.